News › Pharmaceuticals  ·  22 May 2026, 8:57 AM IST  ·  3 months ago

Bullish Signal: Glenmark Pharma, Manappuram Finance Tipped for

VolatileBias: Bullish +5990% confidencePharmaceuticalsFinancial ServicesBullish read

In one line — For Glenmark Pharma, consider a short-term long position, targeting immediate upside. For Manappuram Finance, a similar approach is warranted, focusing on technical levels.

Bearish
Bullish
−1000+59+100

Source: Mint · AI-summarised by Anadi · Updated 22 May 2026, 9:22 AM IST

Pharmaceuticalstilt positive
Financial Servicestilt positive

What Happened

Religare Broking's Ajit Mishra has identified Glenmark Pharmaceuticals and Manappuram Finance as top picks for short-term trading. This direct recommendation from a brokerage firm can influence retail and institutional trading activity in these specific stocks.

Why It Matters (for you)

In a volatile market, specific stock recommendations from reputable brokerages can act as catalysts for price movements, especially for short-term traders. This provides a clear direction for investors looking for alpha in individual scrips, even as the broader indices show mixed cues.

Impact on Indian Markets

Glenmark Pharmaceuticals (GLENMARK) and Manappuram Finance (MANAPPURAM) are likely to see increased buying interest at market open, potentially leading to upward price momentum. The impact is positive for these individual stocks, but the broader market sentiment remains cautious as Nifty and Sensex have been volatile.

What Traders Should Watch Next

Traders should monitor the opening price action and volume for GLENMARK and MANAPPURAM. Look for confirmation of buying interest and set appropriate risk control levels. Also, keep an eye on the overall market sentiment, as a significant downturn could negate individual stock recommendations.

Key Evidence

  • Ajit Mishra from Religare Broking suggests three shares for short-term gains.
  • Glenmark Pharmaceuticals is one of the suggested stocks.
  • Manappuram Finance is another suggested stock.
  • The recommendations come amidst a volatile market.
  • Risk flag: Overall market volatility could override individual stock performance.